ARIDIS PHARMACEUTICALS INC (ARDS)
US0403341045 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.32M | 4.88M | 18.10M | 8.23M | 20.90M | |||
| Receivables | 100.00K | 1.24M | 240.00K | 370.00K | 410.00K | |||
| Other Current Assets | 5.15M | 5.51M | 6.06M | 4.15M | 4.53M | |||
| Total Current Assets | 6.57M | 11.63M | 24.39M | 12.76M | 25.84M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.95M | 2.15M | 1.36M | 1.26M | 1.01M | |||
| Investments And Advances | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Intangibles | 15.00K | 17.00K | 20.00K | 30.00K | 30.00K | |||
| Other Non-Current Assets | 828.00K | 827.00K | 930.00K | 990.00K | 560.00K | |||
| Total Non-Current Assets | 2.87M | 3.07M | 2.41M | 2.36M | 2.13M | |||
| TOTAL ASSETS | 9.43M | 14.70M | 26.80M | 15.12M | 27.97M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 208.00K | 519.00K | 700.00K | 440.00K | N/A | |||
| Accrued Expenses | 9.96M | 10.10M | 6.46M | 1.33M | 2.97M | |||
| Accounts Payable | 6.16M | 6.09M | 5.24M | 1.89M | 1.76M | |||
| Other Current Liabilities | 19.11M | 20.19M | 20.95M | 18.79M | 14.60M | |||
| Total Current Liabilities | 35.43M | 36.90M | 33.35M | 22.44M | 19.33M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 5.28M | 280.00K | 0.00 | |||
| Other Non-Current Liabilities | 1.89M | 2.03M | 1.28M | 1.08M | 5.00M | |||
| Total Non-Current Liabilities | 1.89M | 2.03M | 6.56M | 1.36M | 5.00M | |||
| TOTAL LIABILITIES | 37.32M | 38.93M | 39.91M | 23.80M | 24.33M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -202.48M | -195.67M | -165.30M | -123.10M | -100.77M | |||
| Additional Paid In Capital | 168.68M | 166.38M | 152.18M | 114.42M | 104.40M | |||
| Common Shares | 4.00K | 3.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 5.91M | 5.05M | N/A | N/A | N/A | |||
| Shares Outstanding | 36.08M | 27.03M | 17.70M | 10.07M | 8.92M | |||
| Tangible Book Value per Share | -0.77 | -0.90 | -0.74 | -0.86 | 0.40 | |||
| Total Shareholders' Equity | -27.88M | -24.23M | -13.11M | -8.68M | 3.64M | |||
| TOTAL LIABILITIES AND EQUITY | 9.43M | 14.70M | 26.80M | 15.12M | 27.97M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | -0.40 | -0.03 | N/A | |||
| Current Ratio | 0.19 | 0.32 | 0.73 | 0.57 | 1.34 | |||
| Return On Assets (ROA) | -311.86% | -206.68% | -172.84% | -147.69% | -106.11% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -815.38% | |||
All data in USD